Interaction Between Interferon Regulatory Factor-1 and Human Papillomavirus E7 Oncogene in Cervical Cancer: An Ontology Study

Taiwanese Journal of Obstetrics and Gynecology

Volumn 48, Issue 2, 2009, Pages 138-141

  Wiwanitkit, Viroj ^a  

^a NONE   (Thailand)

Author keywords

cervical cancer; E7 oncogene; human papillomavirus; interferon regulatory factor 1 suppressor protein

Indexed keywords

CYTOKINE; INTERFERON REGULATORY FACTOR 1; PROTEIN E7;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENE TECHNOLOGY; HELPER CELL; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX CANCER; WART VIRUS;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; DATABASES, GENETIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; ONCOGENE PROTEINS, VIRAL; T-LYMPHOCYTES, HELPER-INDUCER; UTERINE CERVICAL NEOPLASMS;

EID: 67749129290     PISSN: None     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60274-6     Document Type: Article

References (12)

1. Dunleavey R. Incidence, pathophysiology and treatment of cervical cancer. Nurs Times 100 (2004) 38-41
2. Tristen C., and Bergstrom S. Cervical cancer in developing countries: a threat to reproductive health. Lakartidningen 93 (1996) 3374-3376 [In Swedish]
3. Birley H.D. Human papillomaviruses, cervical cancer and the developing world. Ann Trop Med Parasitol 89 (1995) 453-463
4. Fiedler M., Muller-Holzner E., Viertler H.P., et al. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J 18 (2004) 1120-1122
5. Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., and Um S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275 (2000) 6764-6769
6. Um S.J., Rhyu J.W., Kim E.J., Jeon K.C., Hwang E.S., and Park J.S. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett 179 (2002) 205-212
7. Khan S., Situ G., Decker K., and Schmidt C.J. GoFigure: automated Gene Ontology annotation. Bioinformatics 19 (2003) 2484-2485
8. Nair S., and Pillai M.R. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 11 (2005) 350-359
9. Lee S.H., Kim J.W., Lee H.W., et al. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 22 (2003) 381-391
10. Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O., and Hakura A. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200 (1994) 130-139
11. Iglesias M., Yen K., Gaiotti D., Hildesheim A., Stoler M.H., and Woodworth C.D. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1α. Oncogene 17 (1998) 1195-1205
12. Luxton J.C., Nath R., Derias N., Herbert A., and Shepherd P.S. Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment. J Gen Virol 84 (2003) 1063-1070